Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2004;43:147-150
Published online before print January 5, 2004, doi: 10.1161/01.HYP.0000113047.47711.fa
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
43/2/147    most recent
01.HYP.0000113047.47711.fav1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DiBona, G. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DiBona, G. F.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure
Hazardous Substances DB
*NITRIC OXIDE

(Hypertension. 2004;43:147.)
© 2004 American Heart Association, Inc.


Hypertension Highlights

The Sympathetic Nervous System and Hypertension

Recent Developments

Gerald F. DiBona

From Departments of Internal Medicine and Physiology & Biophysics, University of Iowa Carver College of Medicine and Veterans Administration Medical Center, Iowa City.

Correspondence to Dr Gerald F. DiBona, Department of Internal Medicine University of Iowa College of Medicine 200 Hawkins Drive Iowa City, IA 52252. E-mail gerald-dibona@uiowa.edu


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Arterial Baroreflex Control of Renal Sympathetic Nerve Activity and the Renal Body Fluid Feedback Mechanism— A Revisionist View

A major hypothesisfor the development of hypertension is that abnormal renal excretory function is critical for the initiation, development, and maintenance of primary hypertension.1 The renal body fluid feedback mechanism couples the long-term regulation of arterial pressure to extracellular volume (sodium and water) homeostasis via pressure natriuresis, whereby the kidneys respond to changes in arterial pressure by altering urinary sodium and water excretion. The obligatory requirement for maintenance of sodium and water balance by the kidneys is believed to be primary in the long-term control of arterial pressure. An increase in arterial pressure (via increases in total peripheral resistance or cardiac output or both) leads to an increased urinary sodium and water excretion via the pressure natriuresis mechanism, with consequent reduction in blood volume until arterial pressure is returned to normal. Thus, factors that decrease renal excretory function and disrupt the maintenance of sodium and water balance by the kidneys lead to an increase in arterial pressure, which is required to reestablish and maintain sodium and water balance. Based on computer modeling studies, a long-term increase in arterial pressure can only occur if there is a chronic and sustained decrease in renal excretory function.

Increased renal sympathetic nerve activity (RSNA) is known to be a factor capable of decreasing renal excretory function.2,3 The renal effects of increased RSNA include increased renal tubular sodium reabsorption leading to renal sodium retention; decreased renal blood flow and glomerular filtration rate with renal vasoconstriction and increased renal vascular resistance; and increased renin release leading . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
HypertensionHome page
M. P. Schlaich, P. A. Sobotka, H. Krum, R. Whitbourn, A. Walton, and M. D. Esler
Renal Denervation as a Therapeutic Approach for Hypertension: Novel Implications for an Old Concept
Hypertension, December 1, 2009; 54(6): 1195 - 1201.
[Full Text] [PDF]


Home page
HypertensionHome page
P. Mathieu, P. Poirier, P. Pibarot, I. Lemieux, and J.-P. Despres
Visceral Obesity: The Link Among Inflammation, Hypertension, and Cardiovascular Disease
Hypertension, April 1, 2009; 53(4): 577 - 584.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
N. A. Lutaif, E. M. Rocha, L. A.Veloso, L. M. Bento, and J. A. R. Gontijo
Renal contribution to thermolability in rats: role of renal nerves
Nephrol. Dial. Transplant., December 1, 2008; 23(12): 3798 - 3805.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. Ren, Z. Mi, and E. K. Jackson
Assessment of Nerve Stimulation-Induced Release of Purines from Mouse Kidneys by Tandem Mass Spectrometry
J. Pharmacol. Exp. Ther., June 1, 2008; 325(3): 920 - 926.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
A L Markel, O E Redina, M A Gilinsky, G M Dymshits, E V Kalashnikova, Y. V Khvorostova, L A Fedoseeva, and G S Jacobson
Neuroendocrine profiling in inherited stress-induced arterial hypertension rat strain with stress-sensitive arterial hypertension
J. Endocrinol., December 1, 2007; 195(3): 439 - 450.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
N. W. Rajapakse, G. A. Eppel, R. E. Widdop, and R. G. Evans
ANG II type 2 receptors and neural control of intrarenal blood flow
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2006; 291(6): R1669 - R1676.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. Song, C. K. Kost Jr., and D. S. Martin
Androgens augment renal vascular responses to ANG II in New Zealand genetically hypertensive rats
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2006; 290(6): R1608 - R1615.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
K. Rahmouni, D. A. Morgan, G. M. Morgan, A. L. Mark, and W. G. Haynes
Role of Selective Leptin Resistance in Diet-Induced Obesity Hypertension
Diabetes, July 1, 2005; 54(7): 2012 - 2018.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
K. Klein, M. Daschner, M. Vogel, J. Oh, T. J. Feuerstein, and F. Schaefer
Impaired Autofeedback Regulation of Hypothalamic Norepinephrine Release in Experimental Uremia
J. Am. Soc. Nephrol., July 1, 2005; 16(7): 2081 - 2087.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Ohkita, Y. Wang, N. D. T. Nguyen, Y.-H. Tsai, S. C. Williams, R. C. Wiseman, P. D. Killen, S. Li, M. Yanagisawa, and C. E. Gariepy
Extrarenal ETB Plays a Significant Role in Controlling Cardiovascular Responses to High Dietary Sodium in Rats
Hypertension, May 1, 2005; 45(5): 940 - 946.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Vitela, M. Herrera-Rosales, J. R. Haywood, and S. W. Mifflin
Baroreflex regulation of renal sympathetic nerve activity and heart rate in renal wrap hypertensive rats
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2005; 288(4): R856 - R862.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. M. Sharma
Is There a Rationale for Angiotensin Blockade in the Management of Obesity Hypertension?
Hypertension, July 1, 2004; 44(1): 12 - 19.
[Abstract] [Full Text] [PDF]